Mednet Logo
HomeQuestion

When a patient with pancreatic cancer received neoadjuvant chemo + chemo-RT, how do you manage an in-field, post operative positive margin?

1
3 Answers
Mednet Member
Mednet Member
Radiation Oncology · Memorial Sloan-Kettering Cancer Center

The data from MD Anderson indicates that patients have a similar survival duration when they have an R1 resection after chemoradiation as when they have an R0 resection, and longer than expected with a positive margin. The Mayo Clinic also has data in rectal cancer where there may be an increased ri...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · University of Nebraska Medical Center

In our institution, we recommend postop adjuvant chemoradiation for a positive margin when a patient has not received neoadjuvant radiation. For patients who have received neoadjuvant radiation, we do not re-irradiate immediately after surgery, instead, we watch and wait and recommend definitive RT ...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · NYU Langone Laura and Isaac Perlmutter Cancer Center

I agree with the comments by Dr. @Dr. First Last and Dr. @Dr. First Last. Other important considerations in this setting pertain to how the surgical margins were assessed for this patient, and, which margins were positive. There is a lot of heterogeneity in how margins have been assessed across cent...

Register or Sign In to see full answer

When a patient with pancreatic cancer received neoadjuvant chemo + chemo-RT, how do you manage an in-field, post operative positive margin? | Mednet